{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:44:50Z","timestamp":1789231490400,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474009"],"award-info":[{"award-number":["82474009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ60530"],"award-info":[{"award-number":["2025JJ60530"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xphs.2026.104192","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:09:53Z","timestamp":1770311393000},"page":"104192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of vancomycin exposure in patients with central nervous system infections using physiologically based pharmacokinetic modeling"],"prefix":"10.1016","volume":"115","author":[{"given":"Ya-xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-586X","authenticated-orcid":false,"given":"Guo-ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104192_bib0001","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1038\/s41598-021-85382-4","article-title":"A hospital-based study on etiology and prognosis of bacterial meningitis in adults","volume":"11","author":"Sunwoo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104192_bib0002","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/IDR.S312175","article-title":"Epidemiological characteristics and drug resistance analysis of cerebrospinal fluid microbial infections in Wenzhou area","volume":"14","author":"Zhou","year":"2021","journal-title":"IDR"},{"key":"10.1016\/j.xphs.2026.104192_bib0003","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/WCO.0000000000000931","article-title":"Central nervous system infections and antimicrobial resistance: an evolving challenge","volume":"34","author":"Nau","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.xphs.2026.104192_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/cr030103a","article-title":"Glycopeptide and lipoglycopeptide antibiotics","volume":"105","author":"Kahne","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.xphs.2026.104192_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-199835030-00005","article-title":"Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections","volume":"35","author":"Nau","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104192_bib0006","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3390\/antibiotics10111421","article-title":"Cerebrospinal fluid concentrations of Meropenem and Vancomycin in ventriculitis patients obtained by TDM-guided continuous infusion","volume":"10","author":"Tiede","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.xphs.2026.104192_bib0007","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.xphs.2026.104192_bib0008","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of Vancomycin into the cerebrospinal fluid: a systematic review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104192_bib0009","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/antibiotics11020173","article-title":"Efficacy of Vancomycin and Meropenem in Central nervous system infections in children and adults: current update","volume":"11","author":"Schneider","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.xphs.2026.104192_bib0010","first-page":"195","article-title":"Administration of Vancomycin at high doses in patients with post neurosurgical meningitis: a comprehensive comparison between continuous infusion and intermittent infusion","volume":"17","author":"Taheri","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.xphs.2026.104192_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.70004","article-title":"PBPK modeling: empowering drug development and precision dosing in China","author":"Yang","year":"2025","journal-title":"CPT Pharmacom Syst Pharma"},{"key":"10.1016\/j.xphs.2026.104192_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107310","article-title":"A physiologically based pharmacokinetic model of voriconazole in human CNS-integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and possible transporter mechanisms","volume":"64","author":"Dong","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xphs.2026.104192_bib0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40262-024-01363-6","article-title":"Predictions of Bedaquiline Central nervous system exposure in patients with tuberculosis meningitis using physiologically based pharmacokinetic modeling","volume":"63","author":"Mehta","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104192_bib0014","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/antibiotics11101293","article-title":"A minimal physiologically based pharmacokinetic model to characterize CNS distribution of metronidazole in Neuro care ICU patients","volume":"11","author":"Chauzy","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.xphs.2026.104192_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108137","article-title":"CPhaMAS: an online platform for pharmacokinetic data analysis based on optimized parameter fitting algorithm","volume":"248","author":"Kuang","year":"2024","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.xphs.2026.104192_bib0016","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40262-016-0475-3","article-title":"Development of a physiologically based pharmacokinetic modelling approach to predict the pharmacokinetics of Vancomycin in critically ill septic patients","volume":"56","author":"Radke","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104192_bib0017","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10928-021-09768-7","article-title":"Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations","volume":"48","author":"Saleh","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.xphs.2026.104192_bib0018","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.xphs.2026.104192_bib0019","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104192_bib0020","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-22-0405","article-title":"Mechanistic modeling of Central nervous system pharmacokinetics and target engagement of HER2 tyrosine kinase inhibitors to inform treatment of breast cancer brain metastases","volume":"28","author":"Li","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xphs.2026.104192_bib0021","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1158\/1078-0432.CCR-17-0983","article-title":"Quantitative and mechanistic understanding of AZD1775 penetration across Human blood\u2013Brain barrier in glioblastoma patients using an IVIVE\u2013PBPK modeling approach","volume":"23","author":"Li","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xphs.2026.104192_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-019-9229-1","article-title":"Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage","volume":"16","author":"Jankovska","year":"2019","journal-title":"Clin Proteom"},{"key":"10.1016\/j.xphs.2026.104192_bib0023","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchromb.2004.06.044","article-title":"Proteomics analysis of human cerebrospinal fluid","volume":"815","author":"Yuan","year":"2005","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.xphs.2026.104192_bib0024","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood\u2013brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.xphs.2026.104192_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1590\/0004-282x-anp-2022-s114","article-title":"Cerebrospinal fluid analysis: current diagnostic methods in central nervous system infectious diseases","volume":"80","author":"Gomes","year":"2022","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.xphs.2026.104192_bib0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12987-022-00372-6","article-title":"The choroid plexus and its role in the pathogenesis of neurological infections","volume":"19","author":"Thompson","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.xphs.2026.104192_bib0027","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.32.1.92","article-title":"Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers","volume":"32","author":"Boeckh","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104192_bib0028","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.31.3.393","article-title":"Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers","volume":"31","author":"Healy","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104192_bib0029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.23.4.603","article-title":"Effects of hepatic function on vancomycin clinical pharmacology","volume":"23","author":"Brown","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104192_bib0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.21.4.575","article-title":"Vancomycin pharmacokinetics in normal and morbidly obese subjects","volume":"21","author":"Blouin","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.xphs.2026.104192_bib0031","first-page":"210","article-title":"Phase I studies on vancomycin hydrochloride for injection","volume":"40","author":"Nakashima","year":"1992","journal-title":"Chemotherapy"},{"key":"10.1016\/j.xphs.2026.104192_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.893089","article-title":"The CSF vancomycin concentration in patients with post-operative intracranial infection can Be predicted by the WBCs to total cells ratio and the serum trough concentration","volume":"13","author":"Fan","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.xphs.2026.104192_bib0033","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jinf.2014.06.010","article-title":"Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study","volume":"69","author":"Shokouhi","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.xphs.2026.104192_bib0034","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12879-025-10834-5","article-title":"Vancomycin versus linezolid for treatment of staphylococcal-associated central nervous system infections","volume":"25","author":"Lahouati","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.xphs.2026.104192_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1005791","article-title":"Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients","volume":"13","author":"Wei","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2026.104192_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00241-23","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of Vancomycin in patients with external ventricular drain","volume":"67","author":"Chen","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104192_bib0037","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xphs.2026.104192_bib0038","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.xphs.2026.104192_bib0039","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/FTD.0000000000000907","article-title":"Cerebrospinal fluid penetration of Vancomycin during continuous infusion therapy in patients with nosocomial ventriculitis","volume":"43","author":"Tuon","year":"2021","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.xphs.2026.104192_bib0040","article-title":"Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2026.104192_bib0041","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12028-012-9784-z","article-title":"Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults","volume":"20","author":"Ng","year":"2014","journal-title":"Neurocrit Care"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:52:51Z","timestamp":1777445571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0022354926000419"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104192","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of vancomycin exposure in patients with central nervous system infections using physiologically based pharmacokinetic modeling","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104192"}}